Vonoprazan 20 mg

DRUG4 trials

Sponsors

Seoul National University Hospital, Indonesia University, Rehman Medical Institute - RMI, King Edward Medical University

Conditions

Cirrhoses, LiverErosive EsophagitisGastroesophageal Reflux DiseaseH Pylori

Phase 1

Study to Evaluate the Influence of Tegoprazan on the Pharmacokinetics of Proguanil in Healthy Volunteers

CompletedNCT04568772

Seoul National University HospitalGastroesophageal Reflux Disease

Start: 2020-11-25End: 2021-08-03Updated: 2021-09-27

Phase 2

Evaluating the Efficacy of Vonoprazan in Preventing Post-Endoscopic Variceal Band Ligation Ulcers: A Randomized Controlled Trial

RecruitingNCT07267260

King Edward Medical UniversityCirrhoses, Liver

Start: 2025-12-16End: 2026-03-05Target: 154Updated: 2025-12-26

Phase 4

Indonesian Study of Vonoprazan Vs Esomeprazole in Erosive Esophagitis

Not yet recruitingNCT06720610

Indonesia UniversityErosive Esophagitis

Start: 2024-12-09End: 2025-06-27Target: 216Updated: 2024-12-17

Comparison of Omeprazole vs Vonoprazon in Treatment of H Pylori Infection

Not yet recruitingNCT07040839

Rehman Medical Institute - RMIH Pylori

Start: 2025-07-31End: 2026-02-28Target: 128Updated: 2025-06-27

Related Papers

Effect of <i>SLC22A1</i> polymorphism on the pharmacokinetics of proguanil in Korean: A semi‐physiologic population pharmacokinetic approach

Clinical and Translational Science2024-12-01

Evaluation of CYP2C19-Mediated Pharmacokinetic Drug Interaction of Tegoprazan, Compared with Vonoprazan or Esomeprazole.

2023-03-1016 citations